Deals, Partnering

Collaboration agreement for validating colorectal biomarker

Posted on 14 January 2014

Tags: ,

IntegraGen announced a collaboration with investigators from the New EPOC study to validate the oncology biomarker hsamiR313p.

hsamiR313p a microRNA whose expression has been shown to be a predictor of progression free survival in patients with metastatic colorectal cancer treated with anti‐EGFR therapy. The New EPOC study is a randomized clinical trial of chemotherapy alone compared to chemotherapy in combination with cetuximab, an anti‐EGFR antibody, in 272 KRAS wild‐type patients with operable metastases from colorectal cancer.

The present collaboration will explore the expression levels of hsamiR313p in both primary and metastatic tumors and determine the ability of the biomarker to predict patient outcomes.

A previously conducted study (link) has reported that hsamir313p expression in primary tumor samples was associated with anti‐EGFR response in KRAS wild‐type patients with mCRC receiving EGFR inhibitor therapy.

Related

Read: Big pharma deal news - latest deal news for top 50 pharma / big pharma companies

Related report: Biomarker Partnering Terms and Agreements

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View:Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View:Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup:Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup:Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe:Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on:LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply